TAYLOR MASON: Open Payments
NPI 1548891716 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 33 payments from 13 companies in 2025. Trend: 2023 $895 · 2024 $2,086 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $332 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $94 |
| GENZYME CORPORATION | 2 | $69 |
| Janssen Biotech, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Braintree Laboratories, Inc. | 3 | $49 |
| Ardelyx, Inc. | 2 | $47 |
| Madrigal Pharmaceuticals | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Organon LLC | 2 | $20 |
Products named: SKYRIZI, XIFAXAN, DUPIXENT, TREMFYA, SUFLAVE, IBSRELA, LINZESS, REZDIFFRA.
Industry payments across OH — which companies pay providers there.
